Polatuzumab Vedotin Combined with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) for Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results of a Phase Ib Dose-Escalation

Authors
Publication date
1 December 2015
Publisher
'American Society of Hematology'

Abstract

WOS:000368020102238International audienceConference: 57th Annual Meeting of the American-Society-of-Hematology - Orlando, FL - DEC 05-08, 201

    Similar works

    Full text

    thumbnail-image

    Available Versions

    HAL-Rennes 1

    redirect
    oaioai:HAL:hal-01290426v1
    Last time updated on 09/11/2016

    Archive Ouverte en Sciences de l'Information et de la Communication

    redirect
    oaioai:HAL:hal-01290426v1
    Last time updated on 29/04/2016